Skip to content
Open access

Visualizing zinc-starved slow-replicating Mycobacterium tuberculosis in neutrophil-rich lung lesions

Aug 2026 · bioRxiv · 0 citations
Biology

Abstract

The months-long treatment for tuberculosis is partially attributed to a minor Mycobacterium tuberculosis (Mtb) subpopulation exhibiting phenotypic drug resistance, although origins of these bacilli in hosts remain unknown. Previously, we observed that mycobacteria respond to growth-restrictive limitations of zinc by accumulating Mrf, and inducing Mpy recruitment to the decoding center of the ribosome, thereby hibernating the ribosome in an inactive state. Mrf accumulation – regulated at both transcriptional and post-translational levels by Zur and Clp, respectively, in a zinc-dependent manner – facilitates the formation of stable Mpy-70S ribosome complex in zinc-starved cells. Here, using a translational fusion of Mrf with a fluorescent-reporter protein we visualized zinc-starved mycobacteria with a physiology conducive for Mpy-dependent ribosome hibernation. About half of zinc-starved mycobacterial population expressed microscopically detectable levels of the reporter and exhibited Mpy-dependent slowdown of growth and isoniazid tolerance in vitro. In chronic, high-burden mouse lung infections, ∼3% of Mtb bacilli expressed the reporter, and the frequency increased to ∼35% upon isoniazid treatment. Transcriptomics of mouse lungs suggests an important role of S100A8/A9 and ZIP2 in neutrophils in zinc mobilization during Mtb infections. Moreover, depletion of neutrophils, or loss of S100A9 caused significant attenuation of zinc starvation response in Mtb. Altogether, the study offers a new approach for visualizing and manipulating slow-replicating Mtb in host tissues. Significance The months-long treatment for tuberculosis is partly attributed to a minor Mycobacterium tuberculosis (Mtb) subpopulation exhibiting phenotypic drug tolerance. While in vitro models have demonstrated a correlation between drug tolerance and metabolic slowdown, origins and locations of such drug tolerant bacilli in hosts remain unknown. Here, we report a fluorescent-reporter-based method to visualize a subpopulation of Mtb bacilli in mouse lungs with slowed growth and increased tolerance to isoniazid, a drug that primarily targets growing bacilli. This approach can further lead to a better understanding of the host conditions underlying the development of these bacilli, and develop new therapeutic approaches.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.